ISPE has released Oral Solid Dosage (OSD) Forms Baseline Guide, Second Edition, at its annual meeting in San Diego this week. The FDA-reviewed publication updates content from the original work to current industry standards, practices, and regulatory requirements.
Read more on the FiercePharmaManufacturing web site…
ISPE has announced a major extension of its Product Quality Lifecycle Implementation® initiative (PQLI®) further into biotechnology. This significant development comes after the decision of the CMC-Biotech Working Group consortium to provide their A-Mab case study to ISPE. The public availability of the final version of this case study will be announced during the PQLI session at the ISPE 2009 Annual Meeting. Read more…
Now you can get event-related updates, post your thoughts, preview exciting gatherings, and experience everything that is the 2009 ISPE Annual Meeting. Stay connected during the before, during, and after the event by…
“ISPE is sensitive to the fact that current economic conditions around the world make it difficult for pharmaceutical manufacturing professionals to obtain the knowledge and training they require,” said ISPE President and CEO Robert P. Best. Read more…
“I’m very pleased with the diverse composition of our incoming Board of Directors,” said ISPE President and CEO Bob Best. “ISPE’s Members can only benefit from the myriad of backgrounds represented by our incoming Board in terms of geography, areas of interest, and areas of expertise.” Read more…
|
Pharmaceutical Industry News Feed |
|
Powered by Congoo |
You are currently browsing the archives for the General ISPE News category.
